2015

Sindhu S, Wilson A, Akther N, Shenouda S, Kochumon S, behbahani K, et al. Increased Adipose Tissue Expression of Toll-Like Receptor (TLR)-7 in Obese Individuals: Significance in Metabolic Disease. J Glycomics Lipidomics. 2015;5(4):1-6.

Ziyab A, Behbahani K, Carballo M. Diabetes: A Fast Evolving Epidemic. Kuwait Medical J. 2015;47(4):291-301.

Behbehani R, Al-Hassan AA, Al-Khars A, Sriraman D, Alroughani R. Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis. J Neurol Sci. 2015;359(1-2):305-8.

Janahi EM, Al-Mannai M, Singh H, Jahromi M. Distribution of Hepatitis C Virus Genotypes in Bahrain. Hepat Mon. 2015;15(12):e30300.

Alroughani R, Akhtar S, Ahmed SF, Al-Hashel JY. Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort. Int J Neurosci. 2015;125(11):831-7

Al-Temaimi RA, Al-Enezi A, Al-Serri A, Al-Roughani R, Al-Mulla F. The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait. PloS one. 2015;10(11):e0142265.

Ahmad R, Al-Roub A, Koshy M, Sindhu S, Behbahani K. Relationship of IL-5 with Th1 and Th2 Cytokines in Individuals with or without Type-2 Diabetes. J Glycomics Lipidomics. 2015;5(4):1-4.

Sindhu S, Thomas R, Kochumon S, Alshawaf E, Hasan A, Alghanim M, Behbehanil K, Ahmad R. Changes in the Adipose Tissue Expression of CD86 Costimulatory Ligand and CD163 Scavenger Receptor in Obesity and Type-2 Diabetes: Implication for Metabolic Disease. J Glycomics Lipidomics. 2015;5(4):1-8.

Alqaderi H, Goodson JM, Tavares M, Al-Mutawa S, Behbahani K, Behbehani J. Short sleep duration as a risk factor for obesity in Kuwaiti children. Integr Obesity Diabetes. 2015;1(5):151-6.

Hassoun AA, Abdella N, Al Arouj M, Awadi FA, Futaisi AA, Lamki MA, et al. Driving and diabetes mellitus in the Gulf Cooperation Council countries: Call for action. Diabetes Res Clin Pract. 2015;110(1):91-4.

Shi P, Goodson JM, Hartman ML, Hasturk H, Yaskell T, Vargas J, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F. Continuous Metabolic Syndrome Scores for Children Using Salivary Biomarkers. PloS one. 2015;10(9):e0138979.

Alroughani R, Thussu A, Guindi RT. Yet Another Atypical Presentation of Anti-GQ1b Antibody Syndrome. Neurol Int. 2015;7(2):5770.

Badawi DA, Alkhamis Y, Qaddoumi M, Behbehani K. National transparency assessment of Kuwait's pharmaceutical sector. Health policy. 2015;119(9):1275-83.

Abu-Farha M, Cherian P, Al-Khairi I, Tiss A, Khadir A, Kavalakatt S, et al. DNAJB3/HSP-40 cochaperone improves insulin signaling and enhances glucose uptake in vitro through JNK repression. Sci Rep. 2015;5:14448.

Ahmad R, Shihab PK, Thomas R, Alghanim M, Hasan A, Sindhu S, Behbehani K. Increased expression of the interleukin-1 receptor-associated kinase (IRAK)-1 is associated with adipose tissue inflammatory state in obesity. Diabetol Metab Syndr. 2015;7:71.

Abu-Farha M, Behbehani K. Characterization of Protein Complexes and Their Implication in Biological Processes. J Proteom Enzymo. 2015;4(2).

Abu-Farha M, Abubaker J, Noronha F, Al-Khairi I, Cherian P, Alarouj M, Bennakhi A, Elkum N. Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects. Cardiovasc Diabetol. 2015;14:112.

Sindhu S, Thomas R, Shihab P, Sriraman D, Behbehani K, Ahmad R. Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation. PloS one. 2015;10(7):e0133494.

Badawi D, Saleh S, Natafgi N, Mourad Y, Behbehani K. Quality of Type II Diabetes Care in Primary Health Care Centers in Kuwait: Employment of a Diabetes Quality Indicator Set (DQIS). PloS one. 2015;10(7):e0132883.

Raizada S, Al Kandari J, Al Diab F, Al Sabah K, Kumar N, Mathew S. Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema. A prospective, randomized comparative study. Indian J Ophthalmol. 2015;63(6):504-10.